换一批
换一批Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England's prescription data during the COVID-19 pandemic (January 2019 to October 2020).
第一作者：
Ravina,Barrett
第一单位：
School of Applied Sciences, University of Brighton, Cockcroft Building, Lewes Road, Moulsecoomb, Brighton BN2 4GJ, UK.
作者：
关键词
COVID-19SARS-CoV-2analysis of varianceangiotensin IIangiotensin-converting enzyme inhibitorsbendroflumethiazidecalcium channel blockerscardiovascular diseasescolesevelam hydrochloridecommunicable disease controlconfidence intervalsdelivery of health carediureticsdoxazosinezetimibefibrinolytic agentshealth services accessibilityhealth status disparitiesheart diseaseshydroxymethylglutaryl-CoA reductase inhibitorsindapamideinterrupted time-series analysisivabradinelife expectancymedication adherencemedicinemidodrinenicorandilnitratespandemicspharmaciespotassium sparingprescriptionsprimary health careranolazineretrospective studiessodium potassium chloride symporter inhibitors
主题词
人类(Humans);疾病大流行(Pandemics);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);苄氟噻嗪(Bendroflumethiazide);回顾性研究(Retrospective Studies);队列研究(Cohort Studies);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);心血管药物(Cardiovascular Agents);心血管疾病(Cardiovascular Diseases);心脏病(Heart Diseases);利尿药(Diuretics);药物处方(Drug Prescriptions)
DOI
10.1177/17539447221137170
PMID
36420815
发布时间
2022-11-30
- 浏览0
Therapeutic advances in cardiovascular disease
17539447221137170页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
